Article Information
PubMed
Published By
History
- Received October 13, 2011
- Revision received February 10, 2012
- Accepted March 1, 2012
- First published April 18, 2012.
- Version of record published April 18, 2012.
Copyright & Usage
Copyright © 2012 the authors 0270-6474/12/325481-05$15.00/0
Author Information
Author contributions
Author contributions: L.D. designed research; R.T. and L.D. performed research; R.T. and L.D. analyzed data; L.D. wrote the paper.
Disclosures
- Received October 13, 2011.
- Revision received February 10, 2012.
- Accepted March 1, 2012.
This work was supported by grants from the Alzheimer's Association (IIRG-09-129984 and ZEN-11-201425), the National Institutes of Health (R01AG033007), a Thome Foundation grant to L.D, and Training Program in Cellular and Molecular Biology and Genetics Grant T32 GM007491 supporting R.T. We thank Alessia P. M. Barbagallo for technical help.
L.D. is an inventor of a patent on the FBDKI mice. The assign is the Albert Einstein College of Medicine. The Albert Einstein College of Medicine has licensed the patent to a Biotech company (Remegenix) of which L.D. is a cofounder.
- Correspondence should be addressed to Luciano D'Adamio, National Research Council of Italy, Cellular Biology and Neurobiology Institute, Via del Fosso del Fiorano, 64, 00143 Roma, Italy. luciano.dadamio{at}einstein.yu.edu
Statistics from Altmetric.com
Article usage
In this issue
Memory Deficits of British Dementia Knock-In Mice Are Prevented by Aβ-Precursor Protein Haploinsufficiency
